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Conclusions 
Over a long period, our proton therapy facility has been reliable and 
accurate in its delivery. As the correctness of each steering file is 
anyway independently checked by a dose calculation based directly on 
the content of the steering file, we are therefore proposing to move 
to a new QA strategy. This will consist of weekly dosimetric 
verifications of only a standard and quasi-randomly selected field, to 
ensure consistency in the performance of the proton facility. This 
policy will improve workflow issues caused by the obligatory field-by-
field verification adopted up to now. 
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Purpose/Objective: During radiotherapy of the prostate, inter- and 
intra-fractional organ motion can cause deviations in prostate location 
of more than 10 mm away from the position assumed during the 
planning stage. This can potentially degrade the dose target coverage. 
In this treatment planning study we have investigated the impact on 
target coverage caused by organ motion when treating prostate 
cancer with protons, with an emphasis on the situation when 
particularly tight margins are applied. The dosimetric effects were 
compared for two the techniques Intensity Modulated Proton Therapy 
(IMPT) and passive proton Double Scattering (DS). 
Materials and Methods: CT scans of 8 prostate cancer patients were 
re-planned with IMPT and DS using the Eclipse Treatment Planning 
system (Varian Medical Systems). The prostate was defined as the 
Clinical Target Volume (CTV) and was expanded isotropically with 2 
mm to define the Planning Target Volume (PTV). The total prescribed 
dose to the PTV was 76 GyRBE and the evaluation was based on 95 % 
target dose coverage of the PTV in addition to normal tissue dose 
constraints. Both the IMPT and DS treatment plans consisted of two 
opposing lateral fields. To simulate prostate organ motion, the CTV 
was shifted 6 mm and 12 mm in posterior/anterior, superior/inferior 
and lateral directions, and plans were re-calculated for each shift 
with the original field and plan parameters.  
Results: CTV shifts in all directions caused degradation in target 
coverage, however, the degradations differed considerably between 
the two treatment techniques. For the 6 mm shifts in the anterior 
direction the mean dose coverage across all patients was reduced to 
88 ± 2 % with DS and was additionally decreased to 81 ± 4 % with IMPT. 
Similar trends were seen also for the posterior as well as the 
superior/inferior directions (Table 1). For the lateral shifts an 
opposite effect was found, with slightly larger dose reduction for DS 
compared to IMPT. The effects for 12 mm shifts were enlarged, with 
larger degradations for the anterior/posterior and superior/inferior 
directions with IMPT (Figure 1), but smaller for lateral shifts.  
 
Conclusions: In this study we have shown that prostate motion can 
cause severe reduction in target coverage. The degradations appear 
to have a higher impact when treating with IMPT than with passive DS. 
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Purpose/Objective: Although Stereotactic Ablative Body Radiotherapy 
(SABR) has become the standard treatment for T1-T2 inoperable non-
small cell lung cancer (NSCLC), the manner in which this is delivered 
may differ between institutes. Often coplanar and non-coplanar IMRT 
with 10 or more beams is performed, resulting in long treatment 
times. Image guidance, imperative for SABR increases this time even 
further, while intrafraction motion has been found to correlate with 
the overall treatment time1. Since the introduction of volumetric 
modulated arc therapy (VMAT), treatment times have been 
considerably reduced. This study aims to evaluate intrafraction 
motion in NSCLC patients treated with IMRT and VMAT based SABR. 
Materials and Methods: NSCLC patients treated with SABR(3x18 Gy) 
were consecutively selected from our database; 100 IMRT and 50 
VMAT. All patients were treated using a frameless technique whereby 
patients were positioned on a mattress with arm and knee support. 
The image guidance protocol for both techniques was identical: 1) a 
1stCBCT was acquired prior to each fraction that was registered using 
a dual registration algorithm on the bony anatomy and the tumour to 
the mid-ventilation planning CT; 2) a couch correction was performed 
to align the tumour; 3) a 2ndCBCT (CBCT2) was acquired to verify the 
correction prior to dose delivery; 4) following a non-coplanar IMRT 
technique or a dual arc VMAT technique, a 3rd CBCT (CBCT3) scan was 
acquired. Intrafraction motion was evaluated between CBCT2 and 
CBCT3. Treatment time was calculated for both techniques and was 
defined as the difference in time between CBCT3 and CBCT2. The 
difference in intrafraction motion between the 2 techniques was 
analysed in terms of the group mean, systematic and random errors. 
